AMGEN INC Quarterly Amortization of Intangible Assets in USD from Q1 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Amgen Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2013 to Q4 2024.
  • Amgen Inc Amortization of Intangible Assets for the quarter ending December 31, 2024 was $1.2B, a 7.05% increase year-over-year.
  • Amgen Inc Amortization of Intangible Assets for the twelve months ending December 31, 2024 was $4.8B, a 50% increase year-over-year.
  • Amgen Inc annual Amortization of Intangible Assets for 2024 was $4.8B, a 50% increase from 2023.
  • Amgen Inc annual Amortization of Intangible Assets for 2023 was $3.2B, a 23.1% increase from 2022.
  • Amgen Inc annual Amortization of Intangible Assets for 2022 was $2.6B, unchanged from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $4.8B $1.2B +$79M +7.05% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-14
Q3 2024 $4.72B $1.2B +$507M +73.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $4.21B $1.2B +$507M +73.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.71B $1.2B +$507M +73.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $3.2B $1.12B +$415M +58.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-14
Q3 2023 $2.79B $693M +$65M +10.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $2.72B $693M +$64M +10.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $2.66B $693M +$56M +8.79% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $2.6B $706M +$54M +8.28% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-14
Q3 2022 $2.55B $628M -$14M -2.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $2.56B $629M -$23M -3.53% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $2.58B $637M -$17M -2.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $2.6B $652M -$18M -2.69% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $2.62B $642M -$66M -9.32% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $2.68B $652M -$61M -8.56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $2.75B $654M -$55M -7.76% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $2.8B $670M +$218M +48.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $2.58B $708M +$390M +123% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $2.19B $713M +$398M +126% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.79B $709M +$394M +125% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $1.4B $452M +$135M +42.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $1.27B $318M -$13M -3.93% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.28B $315M -$17M -5.12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $1.3B $315M -$5M -1.56% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $1.3B $317M +$69M +27.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $1.23B $331M +$23M +7.47% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $1.21B $332M -$39M -10.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $1.25B $320M -$53M -14.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $1.3B $248M -$141M -36.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $1.44B $308M -$63M -17% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $1.5B $371M $0 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $1.5B $373M +$4M +1.08% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $1.5B $389M +$15M +4.01% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $1.49B $371M +$31M +9.12% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $1.45B $371M +$26M +7.54% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $1.43B $369M +$28M +8.21% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $1.4B $374M +$11M +3.03% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $1.39B $340M +$1M +0.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $1.39B $345M +$4M +1.17% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $1.38B $341M -$16M -4.48% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $1.4B $363M +$74M +25.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $1.33B $339M +$222M +190% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $1.1B $341M +$222M +187% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $882M $357M +$240M +205% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $642M $289M Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $117M Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $119M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $117M Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.